image
Healthcare - Medical - Devices - NYSE - US
$ 81.1
0 %
$ 11 B
Market Cap
130.81
P/E
1. INTRINSIC VALUE

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.[ Read More ]

The intrinsic value of one GMED stock under the base case scenario is HIDDEN Compared to the current market price of 81.1 USD, Globus Medical, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart GMED

image
FINANCIALS
1.57 B REVENUE
53.34%
133 M OPERATING INCOME
-41.59%
123 M NET INCOME
-35.39%
243 M OPERATING CASH FLOW
36.44%
303 M INVESTING CASH FLOW
374.52%
-232 M FINANCING CASH FLOW
-110.82%
626 M REVENUE
-0.63%
48.1 M OPERATING INCOME
-24.99%
51.8 M NET INCOME
63.21%
204 M OPERATING CASH FLOW
275.34%
-15 M INVESTING CASH FLOW
-44.22%
19.6 M FINANCING CASH FLOW
124.86%
Balance Sheet Decomposition Globus Medical, Inc.
image
Current Assets 1.92 B
Cash & Short-Term Investments 518 M
Receivables 505 M
Other Current Assets 893 M
Non-Current Assets 3.17 B
Long-Term Investments 75.4 M
PP&E 647 M
Other Non-Current Assets 2.45 B
Current Liabilities 392 M
Accounts Payable 56.7 M
Short-Term Debt 12.4 M
Other Current Liabilities 323 M
Non-Current Liabilities 696 M
Long-Term Debt 508 M
Other Non-Current Liabilities 187 M
EFFICIENCY
Earnings Waterfall Globus Medical, Inc.
image
Revenue 1.57 B
Cost Of Revenue 548 M
Gross Profit 1.02 B
Operating Expenses 887 M
Operating Income 133 M
Other Expenses 10.3 M
Net Income 123 M
RATIOS
65.05% GROSS MARGIN
65.05%
8.49% OPERATING MARGIN
8.49%
7.83% NET MARGIN
7.83%
3.07% ROE
3.07%
2.42% ROA
2.42%
2.24% ROIC
2.24%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Globus Medical, Inc.
image
Net Income 123 M
Depreciation & Amortization 145 M
Capital Expenditures -78.3 M
Stock-Based Compensation 52.7 M
Change in Working Capital -117 M
Others 115 M
Free Cash Flow 165 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Globus Medical, Inc.
image
Wall Street analysts predict an average 1-year price target for GMED of $73 , with forecasts ranging from a low of $60 to a high of $80 .
GMED Lowest Price Target Wall Street Target
60 USD -26.02%
GMED Average Price Target Wall Street Target
73 USD -9.99%
GMED Highest Price Target Wall Street Target
80 USD -1.36%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Globus Medical, Inc.
image
Sold
0-3 MONTHS
12.3 M USD 4
3-6 MONTHS
70 K USD 1
6-9 MONTHS
6.35 M USD 4
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 week ago
Nov 06, 2024
Sell 4.8 M USD
Scavilla Daniel T
President, CEO
- 60000
80.02 USD
1 week ago
Nov 06, 2024
Sell 200 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2500
80.02 USD
1 week ago
Nov 06, 2024
Sell 205 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2500
82 USD
1 month ago
Oct 16, 2024
Sell 563 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 7500
75.0199 USD
1 month ago
Oct 16, 2024
Sell 2.25 M USD
Davidar David D
Director
- 30000
75.0401 USD
1 month ago
Oct 16, 2024
Sell 1.5 M USD
Davidar David D
Director
- 20000
75.0305 USD
2 months ago
Sep 13, 2024
Sell 1.06 M USD
RHOADS ANN D
Director
- 15000
70.36 USD
2 months ago
Sep 13, 2024
Sell 1.76 M USD
Davidar David D
Director
- 25000
70.46 USD
4 months ago
Jul 11, 2024
Sell 70 K USD
Norwalk Leslie V
Director
- 1000
70 USD
6 months ago
May 10, 2024
Sell 4.09 M USD
Lemaitre Dan
Director
- 63300
64.6133 USD
6 months ago
May 08, 2024
Sell 1.3 M USD
Davidar David D
Director
- 20000
65 USD
8 months ago
Mar 15, 2024
Sell 551 K USD
Norwalk Leslie V
Director
- 10590
51.99 USD
8 months ago
Mar 01, 2024
Sell 236 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 4385
53.79 USD
8 months ago
Mar 01, 2024
Sell 170 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 3115
54.53 USD
1 year ago
May 15, 2023
Sell 2.48 M USD
Lemaitre Dan
Director
- 43450
56.9845 USD
1 year ago
Feb 02, 2023
Sell 2.26 M USD
Pfeil Keith W
SVP, Chief Financial Officer
- 29167
77.568 USD
3 years ago
Aug 19, 2021
Sell 63.4 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 833
76.13 USD
1 year ago
Dec 01, 2022
Sell 563 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 7500
75.0001 USD
2 years ago
Apr 19, 2022
Sell 2.46 M USD
Davidar David D
director:
- 31500
78.034 USD
2 years ago
Apr 08, 2022
Sell 189 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2500
75.585 USD
2 years ago
Mar 15, 2022
Sell 579 K USD
TOBIN JAMES R
director:
- 8850
65.471 USD
2 years ago
Mar 08, 2022
Sell 323 K USD
TOBIN JAMES R
director:
- 4484
72 USD
2 years ago
Mar 10, 2022
Sell 700 K USD
TOBIN JAMES R
Director
- 10000
70.0398 USD
3 years ago
Aug 19, 2021
Sell 63.4 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 833
76.13 USD
3 years ago
Aug 02, 2021
Sell 69.3 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 833
83.24 USD
3 years ago
Jul 19, 2021
Sell 65.3 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 834
78.25 USD
3 years ago
Jul 02, 2021
Sell 7.81 M USD
Scavilla Daniel T
EVP, Chief Commercial Officer
- 99600
78.41 USD
3 years ago
Jul 02, 2021
Sell 31.6 K USD
Scavilla Daniel T
EVP, Chief Commercial Officer
- 400
78.97 USD
3 years ago
Jul 01, 2021
Sell 64.5 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 833
77.43 USD
3 years ago
Jun 25, 2021
Sell 2.06 M USD
Pfeil Keith W
SVP, Chief Financial Officer
- 27479
75.04 USD
3 years ago
May 10, 2021
Sell 1.8 M USD
TOBIN JAMES R
Director
- 25000
71.96 USD
3 years ago
May 05, 2021
Sell 377 K USD
Pfeil Keith W
SVP, Chief Financial Officer
- 5021
75 USD
3 years ago
Apr 23, 2021
Sell 8.68 M USD
Demski David M
President, CEO
- 121259
71.59 USD
3 years ago
Apr 26, 2021
Sell 10.3 M USD
Demski David M
President, CEO
- 144263
71.5 USD
3 years ago
Mar 09, 2021
Sell 961 K USD
Lemaitre Dan
Director
- 15384
62.47 USD
3 years ago
Dec 28, 2020
Sell 132 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 2000
66.15 USD
3 years ago
Dec 16, 2020
Sell 3.36 M USD
Demski David M
President, CEO
- 52356
64.2 USD
3 years ago
Dec 17, 2020
Sell 10.6 M USD
Demski David M
President, CEO
- 164719
64.2 USD
4 years ago
Aug 06, 2020
Sell 5.37 M USD
Demski David M
President, CEO
- 96900
55.42 USD
4 years ago
Aug 06, 2020
Sell 3.83 M USD
Demski David M
President, CEO
- 68100
56.24 USD
4 years ago
Aug 06, 2020
Sell 9.41 M USD
Demski David M
President, CEO
- 165000
57.02 USD
3 years ago
Nov 24, 2020
Sell 1.92 M USD
Davidar David D
Director
- 32000
60 USD
3 years ago
Nov 24, 2020
Sell 600 K USD
Davidar David D
Director
- 10000
60 USD
4 years ago
Sep 02, 2020
Sell 318 K USD
TOBIN JAMES R
Director
- 5600
56.85 USD
4 years ago
Aug 25, 2020
Sell 947 K USD
TOBIN JAMES R
Director
- 17400
54.4 USD
4 years ago
Aug 24, 2020
Bought 33.1 K USD
Douglas Robert Andrew
Director
+ 615
53.88 USD
4 years ago
Aug 06, 2020
Sell 5.37 M USD
Demski David M
President, CEO
- 96900
55.42 USD
4 years ago
Aug 06, 2020
Sell 3.83 M USD
Demski David M
President, CEO
- 68100
56.24 USD
4 years ago
Aug 06, 2020
Sell 9.41 M USD
Demski David M
President, CEO
- 165000
57.02 USD
4 years ago
Aug 06, 2020
Sell 329 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 6000
54.78 USD
4 years ago
Aug 06, 2020
Sell 168 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 3000
55.92 USD
4 years ago
Aug 06, 2020
Sell 174 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 3000
57.9 USD
4 years ago
Jul 22, 2020
Bought 32.9 K USD
Douglas Robert Andrew
Director
+ 690
47.75 USD
4 years ago
Jun 22, 2020
Bought 33.7 K USD
Douglas Robert Andrew
Director
+ 700
48.2 USD
4 years ago
Jun 11, 2020
Sell 463 K USD
Huller Kelly
SVP, GC, Corporate Secretary
- 9076
51 USD
4 years ago
May 21, 2020
Sell 5.51 M USD
Scavilla Daniel T
EVP, Chief Commercial Officer
- 100000
55.09 USD
4 years ago
Dec 17, 2019
Sell 380 K USD
Huller Kelly
SVP, General Counsel
- 6460
58.9 USD
5 years ago
Nov 07, 2019
Sell 2.05 M USD
Davidar David D
Director
- 38000
54 USD
5 years ago
Nov 07, 2019
Sell 540 K USD
Davidar David D
Director
- 10000
54.04 USD
5 years ago
Nov 07, 2019
Sell 168 K USD
Huller Kelly
SVP, General Counsel
- 3000
55.9 USD
5 years ago
Nov 01, 2019
Sell 159 K USD
Huller Kelly
SVP, General Counsel
- 3000
52.9 USD
5 years ago
Aug 02, 2019
Sell 150 K USD
Huller Kelly
SVP, General Counsel
- 3000
49.9 USD
5 years ago
Aug 16, 2019
Sell 2.47 M USD
Davidar David D
Director
- 50000
49.3301 USD
5 years ago
Mar 28, 2019
Sell 146 K USD
Huller Kelly
SVP, General Counsel
- 3000
48.59 USD
5 years ago
Mar 05, 2019
Sell 7.8 M USD
Williams Anthony L
President
- 165870
47.05 USD
5 years ago
Mar 06, 2019
Sell 387 K USD
Williams Anthony L
President
- 8386
46.14 USD
5 years ago
Mar 07, 2019
Sell 1.74 M USD
Williams Anthony L
President
- 37826
46.01 USD
5 years ago
Feb 28, 2019
Sell 904 K USD
TOBIN JAMES R
Director
- 18800
48.1 USD
5 years ago
Feb 26, 2019
Sell 400 K USD
TOBIN JAMES R
Director
- 8500
47.06 USD
5 years ago
Feb 28, 2019
Sell 437 K USD
TOBIN JAMES R
Director
- 9300
47.04 USD
5 years ago
Feb 26, 2019
Sell 19.2 K USD
TOBIN JAMES R
Director
- 400
47.91 USD
6 years ago
Sep 26, 2018
Sell 168 K USD
Payne Steven
Chief Accounting Officer
- 3000
56 USD
6 years ago
Sep 25, 2018
Sell 41 M USD
Paul David C
Executive Chairman
- 748845
54.6964 USD
6 years ago
Sep 24, 2018
Sell 5.47 M USD
Paul David C
Executive Chairman
- 101320
54.0126 USD
6 years ago
Jul 17, 2018
Sell 362 K USD
Paul David C
Executive Chairman
- 6841
52.95 USD
6 years ago
Jun 25, 2018
Sell 453 K USD
Schwartz Eric
Senior VP and General Counsel
- 8444
53.638 USD
6 years ago
Jun 25, 2018
Sell 84.9 K USD
Schwartz Eric
Senior VP and General Counsel
- 1556
54.594 USD
6 years ago
Jun 11, 2018
Sell 6.75 M USD
Williams Anthony L
President
- 120267
56.1353 USD
6 years ago
Jun 11, 2018
Sell 79.6 K USD
Williams Anthony L
President
- 1400
56.872 USD
6 years ago
May 31, 2018
Sell 1.16 M USD
Payne Steven
Chief Accounting Officer
- 20771
55.8096 USD
6 years ago
Apr 26, 2018
Sell 2.27 M USD
Paul David C
Executive Chairman
- 43750
51.8068 USD
6 years ago
Apr 26, 2018
Sell 18.8 M USD
Paul David C
Executive Chairman
- 363284
51.8068 USD
6 years ago
Apr 27, 2018
Sell 1.51 M USD
Paul David C
Executive Chairman
- 29066
51.7831 USD
6 years ago
Apr 30, 2018
Sell 3.78 M USD
Paul David C
Executive Chairman
- 72938
51.8053 USD
6 years ago
Apr 19, 2018
Sell 1.47 M USD
Demski David M
Chief Executive Officer
- 28863
51 USD
6 years ago
Apr 18, 2018
Sell 454 K USD
Demski David M
Chief Executive Officer
- 8899
51.0001 USD
6 years ago
Apr 13, 2018
Sell 155 K USD
Demski David M
Chief Executive Officer
- 3043
51 USD
6 years ago
Apr 10, 2018
Sell 1.56 M USD
Scavilla Daniel T
Senior VP and CFO
- 31250
50 USD
6 years ago
Apr 09, 2018
Sell 911 K USD
Scavilla Daniel T
Senior VP and CFO
- 18210
50.0017 USD
6 years ago
Mar 28, 2018
Sell 1.2 M USD
Schwartz Eric
Senior VP and General Counsel
- 24000
50 USD
6 years ago
Mar 08, 2018
Sell 1.52 M USD
Davidar David D
Director
- 30000
50.5003 USD
6 years ago
Dec 15, 2017
Sell 121 K USD
Payne Steven
Chief Accounting Officer
- 3076
39.3019 USD
6 years ago
Dec 13, 2017
Sell 574 K USD
Williams Anthony L
President
- 15000
38.2994 USD
6 years ago
Dec 04, 2017
Sell 751 K USD
Davidar David D
Director
- 18461
40.655 USD
7 years ago
Nov 09, 2017
Sell 1.8 M USD
Murphy A Brett
Group President, Commerical Op
- 51449
35 USD
7 years ago
Nov 10, 2017
Sell 509 K USD
Murphy A Brett
Group President, Commerical Op
- 14551
35 USD
7 years ago
Sep 06, 2017
Sell 450 K USD
Murphy A Brett
President, Commerical Op
- 15000
29.9935 USD
7 years ago
Jun 05, 2017
Sell 516 K USD
Williams Anthony L
President
- 16153
31.941 USD
8 years ago
Aug 04, 2016
Sell 1.75 M USD
Murphy A Brett
Group President, Commerical Op
- 74700
23.3606 USD
8 years ago
Aug 05, 2016
Sell 772 K USD
Murphy A Brett
Group President, Commerical Op
- 32992
23.3936 USD
8 years ago
Jan 06, 2016
Sell 414 K USD
WHEELER KURT
Director
- 15045
27.5 USD
8 years ago
Jan 06, 2016
Sell 412 K USD
LIPTAK ROBERT
Director
- 15000
27.5 USD
9 years ago
Nov 16, 2015
Sell 129 K USD
Murphy A Brett
Group President, Commerical Op
- 5000
25.8 USD
9 years ago
May 28, 2015
Sell 79.7 K USD
Payne Steven
Chief Accounting Officer
- 3076
25.92 USD
9 years ago
Mar 18, 2015
Sell 35.7 M USD
Paul David C
Chief Executive Officer
- 1427079
25 USD
9 years ago
Mar 19, 2015
Sell 12.4 M USD
Paul David C
Chief Executive Officer
- 494921
25 USD
9 years ago
Feb 26, 2015
Sell 845 K USD
Demski David M
President and COO
- 32510
26 USD
10 years ago
Oct 31, 2014
Sell 888 K USD
Davidar David D
Senior VP, Operations
- 38500
23.06 USD
10 years ago
May 02, 2014
Sell 736 K USD
BARON RICHARD A
Senior VP and CFO
- 30000
24.52 USD
10 years ago
Mar 06, 2014
Sell 6.97 M USD
Demski David M
President and COO
- 269829
25.83 USD
10 years ago
Mar 06, 2014
Sell 39.9 K USD
Demski David M
President and COO
- 1500
26.61 USD
10 years ago
Mar 04, 2014
Sell 1.31 M USD
Davidar David D
Senior VP, Operations
- 52500
25 USD
10 years ago
Mar 04, 2014
Sell 562 K USD
Davidar David D
Senior VP, Operations
- 22500
25 USD
10 years ago
Feb 18, 2014
Sell 1.26 M USD
Davidar David D
Vice President, Operations
- 52500
24 USD
10 years ago
Feb 18, 2014
Sell 540 K USD
Davidar David D
Vice President, Operations
- 22500
24 USD
10 years ago
Jan 15, 2014
Sell 1.99 M USD
Demski David M
President and COO
- 96813
20.51 USD
10 years ago
Dec 31, 2013
Sell 64.5 K USD
Demski David M
President and COO
- 3187
20.25 USD
10 years ago
Dec 18, 2013
Sell 32.3 K USD
Demski David M
President and COO
- 1634
19.75 USD
10 years ago
Dec 19, 2013
Sell 383 K USD
Demski David M
President and COO
- 19412
19.75 USD
10 years ago
Dec 20, 2013
Sell 572 K USD
Demski David M
President and COO
- 28954
19.75 USD
10 years ago
Dec 06, 2013
Sell 484 K USD
LIPTAK ROBERT
Director
- 25000
19.36 USD
10 years ago
Dec 03, 2013
Sell 1.01 M USD
Davidar David D
Vice President, Operations
- 52500
19.25 USD
10 years ago
Dec 03, 2013
Sell 433 K USD
Davidar David D
Vice President, Operations
- 22500
19.25 USD
10 years ago
Nov 26, 2013
Sell 132 K USD
Demski David M
President and COO
- 6876
19.25 USD
10 years ago
Nov 27, 2013
Sell 586 K USD
Demski David M
President and COO
- 30447
19.25 USD
11 years ago
Oct 31, 2013
Sell 1.85 M USD
Demski David M
President and COO
- 100000
18.5 USD
11 years ago
Oct 31, 2013
Sell 215 K USD
Demski David M
President and COO
- 11179
19.26 USD
11 years ago
Nov 01, 2013
Sell 28.8 K USD
Demski David M
President and COO
- 1498
19.25 USD
11 years ago
Oct 31, 2013
Sell 869 K USD
Davidar David D
Vice President, Operations
- 47724
18.2 USD
11 years ago
Oct 31, 2013
Sell 372 K USD
Davidar David D
Vice President, Operations
- 20453
18.2 USD
11 years ago
Oct 31, 2013
Sell 82.7 K USD
Davidar David D
Vice President, Operations
- 4545
18.2 USD
11 years ago
Aug 22, 2013
Sell 718 K USD
Demski David M
President and COO
- 40000
17.95 USD
11 years ago
Aug 22, 2013
Sell 74.6 K USD
Demski David M
President and COO
- 4154
17.95 USD
7. News
Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy? The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 1 day ago
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 2 days ago
Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" Globus Medical (GMED) possesses solid growth attributes, which could help it handily outperform the market. zacks.com - 3 days ago
Expanding Global Market, NuVasive Benefits to Aid GMED Stock Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings. zacks.com - 3 days ago
GMED or SONVY: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 4 days ago
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 5 days ago
GMED Q3 Earnings Top, '24 Guidance Raised, Stock Gains in Aftermarket Globus Medical delivers massive sales and earnings growth in the third quarter of 2024. However, margins contract. zacks.com - 1 week ago
Globus Medical, Inc. (GMED) Q3 2024 Earnings Call Transcript Globus Medical, Inc. (NYSE:GMED ) Q3 2024 Earnings Conference Call November 5, 2024 6:00 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Keith Pfeil - COO and CFO Conference Call Participants Matthew Miksic - Barclays Dino Weinstock - Wells Fargo Young Li - Jefferies Shagun Singh - RBC Capital Markets Phil Dantoin - Piper Sandler David Saxon - Needham & Company Steven Lichtman - Oppenheimer Matthew Blackman - Stifel Ryan Zimmerman - BTIG Craig Bijou - BofA Caitlin Cronin - Canaccord Richard Newitter - Truist Securities Operator Welcome to Globus Medical's Third Quarter 2024 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks. seekingalpha.com - 1 week ago
Globus Medical (GMED) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 week ago
Globus Medical (GMED) Beats Q3 Earnings and Revenue Estimates Globus Medical (GMED) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.57 per share a year ago. zacks.com - 1 week ago
Globus Medical Reports Third Quarter 2024 Results AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2024. globenewswire.com - 1 week ago
Globus Medical, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm LOS ANGELES, CA / ACCESSWIRE / November 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. accesswire.com - 1 week ago
8. Profile Summary

Globus Medical, Inc. GMED

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 11 B
Dividend Yield 0.00%
Description Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Contact 2560 General Armistead Avenue, Audubon, PA, 19403 https://www.globusmedical.com
IPO Date Aug. 3, 2012
Employees 5000
Officers Mr. Brian J. Kearns Senior Vice President of Business Development & Investor Relations Mr. Keith W. Pfeil Chief Financial Officer & Chief Operating Officer Mr. Daniel T. Scavilla President, Chief Executive Officer & Director Ms. Kelly G. Huller Esq. Senior Vice President, General Counsel & Secretary Mr. David C. Paul Co-Founder & Executive Chairman